{"id":"https://openalex.org/W2067024769","doi":"https://doi.org/10.1176/ajp.2007.164.4.630","title":"Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D 2 Receptors: a PET Study in Schizophrenia","display_name":"Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D 2 Receptors: a PET Study in Schizophrenia","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W2067024769","doi":"https://doi.org/10.1176/ajp.2007.164.4.630","mag":"2067024769","pmid":"https://pubmed.ncbi.nlm.nih.gov/17403977"},"language":"en","primary_location":{"id":"doi:10.1176/ajp.2007.164.4.630","doi":"https://doi.org/10.1176/ajp.2007.164.4.630","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.2007.164.4.630","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2067024769"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014756145","display_name":"Romina Mizrahi","orcid":"https://orcid.org/0000-0001-6667-7928","observed_orcids":["https://orcid.org/0000-0001-6667-7928"]},"institutions":[{"id":"https://openalex.org/I1338135719","display_name":"Centre for Addiction and Mental Health","ror":"https://ror.org/03e71c577","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1338135719"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Romina Mizrahi","raw_affiliation_strings":["Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5S 2S1"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5S 2S1","institution_ids":["https://openalex.org/I1338135719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047909666","display_name":"Pablo Rusjan","orcid":"https://orcid.org/0000-0003-0075-2918","observed_orcids":["https://orcid.org/0000-0003-0075-2918"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pablo Rusjan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056037962","display_name":"Ofer Agid","orcid":"https://orcid.org/0000-0001-6881-8296","observed_orcids":["https://orcid.org/0000-0001-6881-8296"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ofer Agid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087838256","display_name":"Ariel Graff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ariel Graff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087173411","display_name":"David C. Mamo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David C. Mamo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088989011","display_name":"Robert B. Zipursky","orcid":"https://orcid.org/0000-0002-1655-883X","observed_orcids":["https://orcid.org/0000-0002-1655-883X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert B. Zipursky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037602769","display_name":"Shitij Kapur","orcid":"https://orcid.org/0000-0002-2231-2924","observed_orcids":["https://orcid.org/0000-0002-2231-2924"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shitij Kapur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.365,"has_fulltext":false,"cited_by_count":166,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96985463,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"164","issue":"4","first_page":"630","last_page":"630"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.9559999704360962},{"id":"https://openalex.org/keywords/dysphoria","display_name":"dysphoria","score":0.7480000257492065},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7630000114440918},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/recent-onset-psychosis","display_name":"recent-onset psychosis","score":0.8510000109672546},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/motor-side-effects","display_name":"motor side effects","score":0.6480000019073486},{"id":"https://openalex.org/keywords/antipsychotic-discontinuation","display_name":"antipsychotic discontinuation","score":0.7990000247955322},{"id":"https://openalex.org/keywords/11c-raclopride","display_name":"[11C]raclopride","score":0.8130000233650208},{"id":"https://openalex.org/keywords/11c-flb-457","display_name":"[11C]FLB 457","score":0.9750000238418579}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8249778747558594},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.7644424438476562},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6567363142967224},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.6324739456176758},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.6097021102905273},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5311291217803955},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5230639576911926},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5136908888816833},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.48782041668891907},{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.44648435711860657},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.43426400423049927},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4140459895133972},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.407673716545105},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37368518114089966},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3244180679321289},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28925013542175293}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002250","descriptor_name":"Carbon Radioisotopes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020891","descriptor_name":"Raclopride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1176/ajp.2007.164.4.630","doi":"https://doi.org/10.1176/ajp.2007.164.4.630","is_oa":false,"landing_page_url":"https://doi.org/10.1176/ajp.2007.164.4.630","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"doi:10.1176/appi.ajp.164.4.630","doi":"https://doi.org/10.1176/appi.ajp.164.4.630","is_oa":false,"landing_page_url":"https://doi.org/10.1176/appi.ajp.164.4.630","pdf_url":null,"source":{"id":"https://openalex.org/S116025658","display_name":"American Journal of Psychiatry","issn_l":"0002-953X","issn":["0002-953X","1535-7228"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316602","host_organization_name":"American Psychiatric Association","host_organization_lineage":["https://openalex.org/P4310316602"],"host_organization_lineage_names":["American Psychiatric Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:17403977","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17403977","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of psychiatry","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W571667285","https://openalex.org/W1492008158","https://openalex.org/W1965036463","https://openalex.org/W1970015451","https://openalex.org/W1972278987","https://openalex.org/W1976182760","https://openalex.org/W1981327315","https://openalex.org/W1981641543","https://openalex.org/W1984145644","https://openalex.org/W1992316682","https://openalex.org/W1996155833","https://openalex.org/W2019053590","https://openalex.org/W2023504580","https://openalex.org/W2026226157","https://openalex.org/W2036424845","https://openalex.org/W2037457092","https://openalex.org/W2042276399","https://openalex.org/W2042626581","https://openalex.org/W2066824070","https://openalex.org/W2071235832","https://openalex.org/W2071707713","https://openalex.org/W2078782277","https://openalex.org/W2079503609","https://openalex.org/W2081029036","https://openalex.org/W2081308285","https://openalex.org/W2083783732","https://openalex.org/W2089223079","https://openalex.org/W2095312095","https://openalex.org/W2117669265","https://openalex.org/W2117671988","https://openalex.org/W2135492979","https://openalex.org/W2138718114","https://openalex.org/W2144062147","https://openalex.org/W2144538553","https://openalex.org/W2147711803","https://openalex.org/W2156547328","https://openalex.org/W2159537672","https://openalex.org/W2162865819","https://openalex.org/W2166684116","https://openalex.org/W2333089169","https://openalex.org/W2907612827"],"related_works":["https://openalex.org/W2162865819","https://openalex.org/W1991467174","https://openalex.org/W1492008158","https://openalex.org/W2094719527","https://openalex.org/W2065731805","https://openalex.org/W4285590563","https://openalex.org/W2088489501","https://openalex.org/W2048766195","https://openalex.org/W2156547328"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Antipsychotic":[1],"medications":[2],"improve":[3],"psychosis":[4,69],"but":[5],"often":[6],"induce":[7],"a":[8],"state":[9],"of":[10,15,79,109,145,210,231],"dysphoria":[11],"in":[12,31,122,184,203,227],"patients.":[13],"Blockade":[14],"the":[16,40,47,123,152,198,207,229],"dopamine":[17,53,92,115,160],"D(2)":[18,54,93,116,175],"receptors,":[19],"which":[20],"is":[21,178],"thought":[22],"to":[23,45,74,197],"mediate":[24],"their":[25],"efficacy,":[26],"has":[27],"also":[28],"been":[29],"implicated":[30],"producing":[32],"this":[33],"adverse":[34,62],"subjective":[35,63,135,182,192,213],"experience.":[36,64,136],"The":[37,137],"authors":[38],"present":[39],"first":[41],"double-blind":[42],"controlled":[43],"study":[44],"examine":[46],"relationship":[48,154],"between":[49],"striatal":[50,89,124],"and":[51,58,61,88,90,98,119,126,129,148,151,167,169,215],"extrastriatal":[52,91],"receptor":[55,117,161,176],"binding":[56,120,164],"potential":[57,165],"occupancy":[59,118,171,177],"values":[60,166],"METHOD:":[65],"Patients":[66],"with":[67,96,134,141,180,218],"recent-onset":[68],"(N=12)":[70],"were":[71,104,132],"randomly":[72],"assigned":[73],"low":[75],"or":[76,81,188],"high":[77,199],"doses":[78],"olanzapine":[80],"risperidone.":[82],"Subjective":[83],"experiences,":[84],"motor":[85],"side":[86],"effects,":[87],"receptors":[94],"(determined":[95],"[(11)C]raclopride":[97],"[(11)C]FLB":[99],"457":[100],"PET":[101],"scans,":[102],"respectively)":[103],"evaluated":[105],"after":[106],"2":[107],"weeks":[108],"continuous":[110],"antipsychotic":[111],"treatment.":[112],"RESULTS:":[113],"Higher":[114,174],"potentials":[121],"(dorsal":[125],"ventral),":[127],"temporal,":[128],"insular":[130],"regions":[131],"associated":[133,179],"finding":[138],"was":[139,155],"confirmed":[140],"two":[142,158],"convergent":[143],"methods":[144],"analysis":[146],"(region-of-interest":[147],"voxel-based":[149],"statistics),":[150],"same":[153],"observed":[156],"using":[157],"different":[159],"measures":[162],"(observed":[163],"age-":[168],"sex-corrected":[170],"values).":[172],"CONCLUSIONS:":[173],"negative":[181,191,212],"experience":[183],"patients":[185],"taking":[186],"risperidone":[187],"olanzapine.":[189],"These":[190],"effects":[193],"may":[194,224],"be":[195,225],"related":[196],"discontinuation":[200],"rates":[201],"seen":[202],"usual":[204],"practice.":[205],"Understanding":[206],"neurobiological":[208],"mechanism":[209],"these":[211],"experiences":[214],"developing":[216],"antipsychotics":[217],"novel":[219],"(i.e.,":[220],"non":[221],"D(2))":[222],"mechanisms":[223],"critical":[226],"improving":[228],"treatment":[230],"psychosis.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2067024769","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
